2020 has been a banner year for the psychedelic therapy market and is a vertical that we have been highly focused on. So far this year, there has been a large increase in the number of companies that are focused on this burgeoning market and this is a trend that…
Cybin Corp., a mushroom life sciences company focused on psychedelic medicines and nutraceutical products, is pleased to announce that it has entered into an amalgamation agreement dated June 26, 2020 with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly-owned subsidiary of Clarmin. Completion of the transactions contemplated…
We have seen a substantial increase in interest in psychedelic focused businesses during the last month and this is a trend that our readers need to be aware of. The psychedelic sector has recently come under pressure and we encourage our readers to conduct significant due diligence on companies in…
Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is developing technologies and analytics that seek to personalize psychedelic therapy experiences for a specific patient. The technology aims to optimize the dosing of MDMA, LSD and other psychedelics based on a patient's profile.…
Rritual, the premium brand in the emerging functional mushroom market, announced today that Dr. Mike Hart has been named as the President of North America's leading mushroom adaptogens company. Dr. Hart has more than 6 years of experience in plant based therapy, including owning and operating his own family medicine clinic in London, Ontario, Canada where he…
During the last month, we have noticed a significant increase in activity in the psychedelic sector and this is a trend that has caught our attention. The sector looks similar to the cannabis industry in 2016/2017 as companies are lining up to go public on a stock exchange. Earlier this…
NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has welcomed Dr. Carolyn Myers, Ph.D. to provide business strategy and business development consulting services to the Company. Dr. Carolyn…
Last month, we issued an update on Cybin Corp after having the opportunity to speak with members of the management team. Following our conversation, we felt much more comfortable with the business and want to provide a more in-depth look at the opportunity. Cybin is a life sciences company that…
PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") is pleased to announce that it has received conditional approval from the Canadian Securities Exchange for the previously announced (see press release dated June 2, 2020) grant of 5,000,000 options (the "Options") to Terry Booth. Each Option is exercisable for…
So far this year, we have noticed a significant increase in the amount of interest in the psychedelic therapy market and this is a trend that we are closely following. Following the completion of a few successful reverse takeovers, we have started to see a spike in the number of…
